Ascentage Pharma, Takeda and IPO
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
Venture Global launched its initial public offering with a lofty goal: Raise up to $2.3 billion at a $110 billion valuation ...
The upcoming IPO has already created a buzz in the grey market. According to stock market observers, shares of Dr Agarwal's ...
Dr Agarwals Eye Hospital's IPO aims to raise Rs 3,027.26 crore, with funds allocated for debt repayment and general corporate purposes. The leading eye care provider operates across India and Africa.
The company's public listing is set to attract attention as it aims to raise Rs 600 crore with shares priced between Rs ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback